Advertisement

Do antioxidants and polyunsaturated fatty acids have a combined association with coronary atherosclerosis?

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      To evaluate the antioxidant hypothesis with regard to atherosclerosis, we compared plasma selenium, serum α-tocopherol, serum polyunsaturated fatty acids (PUFA), and the ratios of selenium and α-tocopherol to PUFAs in subjects with varying degrees of coronary atherosclerosis. Cases had more than 85% stenosis in at least one coronary vessel and controls had less than 50% stenosis in all three vessels Plasma selenium was significantly lower in cases than controls (95.1 ± 21.0 μg/1) and 108 ± 29.3 μg/1, respectively). Though α-tocopherol and PUFA levels were similar in both groups, the ratios Se/linoleic acid, Se/total PUFA and Se/total n - 6 acids were significantly lower in cases. In particular, these differences were observed in subjectes with low serum α-tocopherol level (below the median; 1452 μg/dl). Moreover, in this subgroup the ratio SE/PUFA was significantly lower in cases than in controls for all PUFAs except eicosapentaenoic and docosahexaenoic acid. Though definitive conclusions cannot be drawn from our data, it is hypothesized that high PUFA levels, when insufficiently protected by antioxidants against peroxidation, may indicate a higher risk of atherosclerosis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ross R.
        The pathogenesis of atherosclerosis - an update.
        N. Engl. J. Med. 1986; 314: 488
        • Hennig B.
        • Chow K.C.
        Lipid peroxidation and endothelial cell injury: implications in atherosclerosis.
        Free Rad. Biol. Med. 1988; 4: 99
        • Steinberg D.
        • Parthasarathy S.
        • Carew T.E.
        • Khoo J.C.
        • Witztum J.L.
        Beyond cholesterol— modifications of low-density lipoprotein that increase its atherogenicity.
        N. Engl. J. Med. 1989; 320: 915
        • Stringer M.D.
        • Görög P.G.
        • Freeman A.
        • Kakkar V.V.
        Lipid peroxides and atherosclerosis.
        Br. Med. J. 1989; 298: 281
        • Uysal M.
        • Buler H.
        • Sener D.
        • Oz H.
        Lipid peroxidation in patients with essential hypertension.
        Int. J. Clin. Pharmacol. Res. 1986; 24: 474
        • Sato Y.
        • Hotta N.
        • Sakamoto N.
        • Matsuoka S.
        • Ohishi N.
        • Yagi K.
        Lipid peroxide level in plasma of diabetic patients.
        Biochem. Med. 1979; 21: 104
        • Gey K.F.
        On the antioxidant hypothesis with regard to atherosclerosis.
        Biblthca. Nutr. Dieta. 1986; 37: 53
        • Kok F.J.
        • de Bruijn A.M.
        • Vermeeren R.
        • Hofman A.
        • van Laar A.
        • de Bruin M.
        • Hermus R.J.J.
        • Valkenburg H.A.
        Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands.
        Am. J. Clin. Nutr. 1987; 45: 462
        • Bieri J.G.
        • Tolliver T.J.
        • Catignani G.L.
        Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high-pressure liquid chromatography.
        Am. J. Clin. Nutr. 1979; 32: 2143
        • Folch J.
        • Lees M.
        • Sloane-Stanley G.H.
        A simple method for the isolation and purification of total lipids from animal tissues.
        J. Biol. Chem. 1957; 226: 497
        • Salonen J.T.
        • Alfthan G.
        • Pikkarainen J.
        • Huttunen J.K.
        • Puska P.
        Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study.
        Lancet. 1982; i: 175
        • Salonen J.T.
        • Salonen R.
        • Penttil L.
        • Herranen J.
        • Jauhiainen M.
        • Kantola M.
        • Lappetelinen R.
        • Menp P.H.
        • Alfthan G.
        • Puska P.
        Serum fatty acids, apoGpoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease.
        Am. J. Cardiol. 1985; 56: 226
        • Virtamo J.
        • Valkeila E.
        • Alfthan G.
        • Punsar S.
        • Huttunen J.K.
        • Karvonen M.J.
        Serum selenium and the risk of coronary heart disease and stroke.
        Am. J. Epidemiol. 1985; 122: 276
        • Miettinen T.A.
        • Alfthan G.
        • Huttunen J.K.
        • Pikkarainen J.
        • Naukkarinen V.
        • Mattila S.
        • Kumlin T.
        Serum selenium concentration related to myocardial infarction and fatty acid content of serum lipids.
        Br. Med. J. 1983; 287: 517
        • Kok F.J.
        • Hofman A.
        • Witteman J.C.M.
        • de Bruijn A.M.
        • Kruyssen D.H.C.M.
        • de Bruin M.
        • Valkenburg H.A.
        Decreased selenium levels in acute myocardial infarction.
        JAMA. 1989; 261: 1161
        • Moore J.A.
        • Noiva R.
        • Wells I.C.
        Selenium concentrations in plasma of patients with arteriographically defined atherosclerosis.
        Clin. Chem. 1984; 30: 1171
        • Aro A.
        • Alfthan G.
        • Soimakakkio S.
        • Voutilainen E.
        Se concentrations in serum and angiographically defined coronary artery disease are uncorrelated.
        Clin. Chem. 1986; 32: 911
        • McCord J.M.
        Free radicals and myocardial ischemia: overview and outlook.
        Free Rad. Biol. Med. 1988; 4: 9
        • Hoekstra W.G.
        Biochemical function of selenium and its relation to vitamin E.
        in: Federation Proc.34. 1975: 2083
      1. Nutr. Rev. 1988; 46 (Anonymous): 206
        • Ingold K.U.
        • Webb A.C.
        • Witter D.
        • Burton G.W.
        • Metcalfe T.A.
        • Muller D.P.R.
        Vitamin E remains the major lipid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency.
        Arch. Biochem. Biophys. 1987; 259: 224
        • Pascoe M.A.
        • Farris M.W.
        • Olafsdottir K.
        • Reed D.J.
        A role of vitamin E in protection against cell injury.
        Eur. J. Biochem. 1987; 106: 241
        • Tappel A.L.
        Vitamin E as the biological lipid antioxidant.
        Vitamins Hormones. 1962; 20: 493
        • Diplock A.T.
        Possible stabilizing effect of vitamin E on microsomal, membrane-bound, selenide-containing proteins and drug-metabolizing enzyme systems.
        Am. J. Clin. Nutr. 1974; 27: 995
      2. Nutr. Rev. 1988; 46 (Annonymous): 136
        • Niki E.
        • Tsuchiya F.
        • Tanimura R.
        • Kamiya Y.
        Regeneration of vitamin E from romanoxyl radiacl by glutathione and vitamin C.
        Chem. Lett. 1982; : 789
        • Pryor W.A.
        • Hales B.J.
        • Premovic P.J.
        The radicals in cigarette tar: their nature and suggested physiological implications.
        Science. 1983; 220: 425